These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36871751)
21. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease. Ma T J Neurochem; 2023 Jul; 166(1):47-57. PubMed ID: 34796967 [TBL] [Abstract][Full Text] [Related]
22. Alcohol regulates eukaryotic elongation factor 2 phosphorylation via an AMP-activated protein kinase-dependent mechanism in C2C12 skeletal myocytes. Hong-Brown LQ; Brown CR; Huber DS; Lang CH J Biol Chem; 2007 Feb; 282(6):3702-12. PubMed ID: 17164244 [TBL] [Abstract][Full Text] [Related]
23. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia. Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286 [TBL] [Abstract][Full Text] [Related]
24. Regulating eEF2 and eEF2K in skeletal muscle by exercise. Salimi K; Alvandi M; Saberi Pirouz M; Rakhshan K; Howatson G Arch Physiol Biochem; 2024 Oct; 130(5):503-514. PubMed ID: 36633938 [TBL] [Abstract][Full Text] [Related]
25. Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice. Kasica NP; Zhou X; Yang Q; Wang X; Yang W; Zimmermann HR; Holland CE; Koscielniak E; Wu H; Cox AO; Lee J; Ryazanov AG; Furdui CM; Ma T J Neurochem; 2022 Mar; 160(5):524-539. PubMed ID: 34932218 [TBL] [Abstract][Full Text] [Related]
26. Eukaryotic elongation factor 2 kinase activation in M. soleus under 14-day hindlimb unloading of rats. Lomonosova YN; Belova SP; Mirzoev TM; Kozlovskaya IB; Shenkman BS Dokl Biochem Biophys; 2017 May; 474(1):165-167. PubMed ID: 28726101 [TBL] [Abstract][Full Text] [Related]
27. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. Smith EM; Proud CG EMBO J; 2008 Apr; 27(7):1005-16. PubMed ID: 18337751 [TBL] [Abstract][Full Text] [Related]
28. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533 [TBL] [Abstract][Full Text] [Related]
29. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937 [TBL] [Abstract][Full Text] [Related]
30. PQBP1 promotes translational elongation and regulates hippocampal mGluR-LTD by suppressing eEF2 phosphorylation. Shen Y; Zhang ZC; Cheng S; Liu A; Zuo J; Xia S; Liu X; Liu W; Jia Z; Xie W; Han J Mol Cell; 2021 Apr; 81(7):1425-1438.e10. PubMed ID: 33662272 [TBL] [Abstract][Full Text] [Related]
31. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation. Zhang HM; Wang F; Qiu Y; Ye X; Hanson P; Shen H; Yang D Biochem J; 2016 Feb; 473(4):473-85. PubMed ID: 26621875 [TBL] [Abstract][Full Text] [Related]
32. S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Mieulet V; Roceri M; Espeillac C; Sotiropoulos A; Ohanna M; Oorschot V; Klumperman J; Sandri M; Pende M Am J Physiol Cell Physiol; 2007 Aug; 293(2):C712-22. PubMed ID: 17494629 [TBL] [Abstract][Full Text] [Related]
33. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. Wang X; Li W; Williams M; Terada N; Alessi DR; Proud CG EMBO J; 2001 Aug; 20(16):4370-9. PubMed ID: 11500364 [TBL] [Abstract][Full Text] [Related]
34. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases. Beretta S; Gritti L; Verpelli C; Sala C Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293 [TBL] [Abstract][Full Text] [Related]
35. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. Kenney JW; Moore CE; Wang X; Proud CG Adv Biol Regul; 2014 May; 55():15-27. PubMed ID: 24853390 [TBL] [Abstract][Full Text] [Related]
36. Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance. Smith PR; Loerch S; Kunder N; Stanowick AD; Lou TF; Campbell ZT Nat Commun; 2021 Nov; 12(1):6789. PubMed ID: 34815424 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression. De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820 [TBL] [Abstract][Full Text] [Related]
38. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer. Fu LL; Xie T; Zhang SY; Liu B Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961 [TBL] [Abstract][Full Text] [Related]